Please login to the form below

Not currently logged in
Email:
Password:

BioNTech

This page shows the latest BioNTech news and features for those working in and with pharma, biotech and healthcare.

US FDA expands COVID-19 booster jabs to all adults

US FDA expands COVID-19 booster jabs to all adults

All Americans 18 and over are now eligible to receive a booster shot of either the Pfizer/BioNTech or Moderna COVID-19 vaccines. ... Now, all adults can receive a booster shot six months after a second dose of the Moderna or Pfizer/BioNTech vaccine or

Latest news

More from news
Approximately 73 fully matching, plus 125 partially matching documents found.

Latest Intelligence

  • Rare genetic diseases – what’s in store for 2021? Rare genetic diseases – what’s in store for 2021?

    So far the Pfizer/BioNTech, Moderna and AstraZeneca/Oxford University vaccines have all received approval in the UK and other countries for the very disease that put all these changes into

  • Working together against COVID-19 Working together against COVID-19

    Beyond the connection between HCPs and pharma or NGOs, it is encouraging to see collaborations such as Clover and GSK evaluating a vaccine candidate and Pfizer and Biontech doing the same.

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    BioNTech, CureVac and Translate Bio are also working on mRNA vaccines, while Pfizer and Sanofi are involved in those programmes through partnerships with BioNTech and Translate Bio, respectively.

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    Candidates from Neon Therapeutics, Aduro and BioNTech have passed early-stage testing and are now being studied along with checkpoint inhibitors to see if they can deliver a double-whammy to

  • Deal Watch September 2016 Deal Watch September 2016

    At a lower disclosed headline value of $310m BioNTech licensed its mRNA-based cancer vaccines platform to Genentech. ... The full value cannot be determined as BioNTech received the $310m in upfront and near-term milestone payments, no other financial

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • New hires at bluebird bio, BioNTech and Provention Bio New hires at bluebird bio, BioNTech and Provention Bio

    BioNTech. German biotech BioNTech has appointed Ryan Richardson(pictured below, right) as chief strategy officer and managing director. ... In his new role, he will support and contribute to the creation and implementation of BioNTech’s long-term growth

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...